Login Register Cart 0
Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in Pancreatic Cancer Cells

Author(s): Xiaopeng Cao*, Yi Cao, Hui Zhao, Pengfei Wang and Ziman Zhu

Volume 18, Issue 5, 2023

Published on: 22 September, 2022

Page: [712 - 719] Pages: 8

DOI: 10.2174/1574888X17666220827113434

Price: $65

Abstract

Introduction: Cancer stem cells (CSCs) are profoundly implicated in tumor initiation and progression as well as drug resistance and tumor recurrence of many cancer types, especially pancreatic ductal adenocarcinoma (PDAC). Previously, we revealed that prolyl 4-hydroxylase subunit alpha 1 (P4HA1) enhances the Warburg effect and tumor growth in PDAC. However, the possible connection between P4HA1 and cancer stemness in PDAC remains obscure. In this study, P4HA1-dependent cancer stemness was studied by sphere-formation assay and detection of stemness markers.

Methods: Glycolytic capacity in cancer stem cells and their parental tumor cells was investigated by glucose uptake, lactate secretion, and expression of glycolytic genes. Glycolysis inhibitors were used to determine the link between cancer stemness and glycolysis. A subcutaneous xenograft model was generated to investigate P4HA1-induced stemness and glycolysis in vivo.

Results: We revealed that ectopic expression of P4HA1 increased the stemness of PDAC cells as evidenced by the increased proportion of CD133+ cells, elevated sphere-formation ability, and the upregulated levels of cancer stemness-related proteins (SOX2, OCT4, and NANOG). Blocking tumor glycolysis with 2-Deoxy-D-glucose (2-DG) or a selective inhibitor of glucose transporter 1 (STF-31) significantly reduced the stem properties of PDAC cells, suggesting that P4HA1-induced glycolysis was essential for the stem-like phenotype of PDAC cells. In addition, in vivo study reaffirmed a promotive effect of P4HA1 on tumor glycolysis and cancer stemness.

Conclusion: Collectively, our findings suggest that P4HA1 not only affects tumor metabolic reprogramming but also facilitates cancer stemness, which might be exploited as a vulnerable target for PDAC treatment.

Keywords: P4HA1, warburg effect, pancreatic cancer, cancer stemness, cancer stem cells, glucose metabolism.

« Previous Next »
Graphical Abstract

[1]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[2]
Barman S, Fatima I, Singh AB, Dhawan P. Pancreatic cancer and therapy: Role and regulation of cancer stem cells. Int J Mol Sci 2021; 22(9): 22.
[http://dx.doi.org/10.3390/ijms22094765] [PMID: 33946266]
[3]
Hermann PC, Sainz B Jr. Pancreatic cancer stem cells: A state or an entity? Semin Cancer Biol 2018; 53: 223-31.
[http://dx.doi.org/10.1016/j.semcancer.2018.08.007] [PMID: 30130664]
[4]
Rodriguez-Aznar E, Wiesmüller L, Sainz B Jr, Hermann PC. EMT and stemness-key players in pancreatic cancer stem cells. Cancers (Basel) 2019; 11(8): 11.
[http://dx.doi.org/10.3390/cancers11081136] [PMID: 31398893]
[5]
Khalaf N, Wolpin BM. Metabolic alterations as a signpost to early pancreatic cancer. Gastroenterology 2019; 156(6): 1560-3.
[http://dx.doi.org/10.1053/j.gastro.2019.03.028] [PMID: 30926350]
[6]
Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11(2): 85-95.
[http://dx.doi.org/10.1038/nrc2981] [PMID: 21258394]
[7]
Gunda V, Kumar S, Dasgupta A, Singh PK. Hypoxia-induced metabolomic alterations in pancreatic cancer cells. Methods Mol Biol 2018; 1742: 95-105.
[http://dx.doi.org/10.1007/978-1-4939-7665-2_9] [PMID: 29330793]
[8]
Jiang SH, Li J, Dong FY, et al. Increased serotonin signaling contributes to the warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology 2017; 153(1): 277-291.e19.
[http://dx.doi.org/10.1053/j.gastro.2017.03.008] [PMID: 28315323]
[9]
Belisario DC, Kopecka J, Pasino M, et al. Hypoxia dictates metabolic rewiring of tumors: Implications for chemoresistance. Cells 2020; 9(12): 9.
[http://dx.doi.org/10.3390/cells9122598] [PMID: 33291643]
[10]
Daniel Y, Lelou E, Aninat C, Corlu A, Cabillic F. Interplay between metabolism reprogramming and epithelial-to-mesenchymal transition in cancer stem cells. Cancers (Basel) 2021; 13(8): 13.
[http://dx.doi.org/10.3390/cancers13081973] [PMID: 33923958]
[11]
Tuy K, Rickenbacker L, Hjelmeland AB. Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance. Redox Biol 2021; 44: 101953.
[http://dx.doi.org/10.1016/j.redox.2021.101953] [PMID: 34052208]
[12]
Chen YY, Wang WH, Che L, et al. BNIP3L-dependent mitophagy promotes HBx-induced cancer stemness of hepatocellular carcinoma cells via glycolysis metabolism reprogramming. Cancers (Basel) 2020; 12(3): 12.
[http://dx.doi.org/10.3390/cancers12030655] [PMID: 32168902]
[13]
Yang T, Shu X, Zhang HW, et al. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis. Cell Death Dis 2020; 11(10): 870.
[http://dx.doi.org/10.1038/s41419-020-03087-4] [PMID: 33067426]
[14]
Gorres KL, Raines RT. Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 2010; 45(2): 106-24.
[http://dx.doi.org/10.3109/10409231003627991] [PMID: 20199358]
[15]
Cao XP, Cao Y, Li WJ, Zhang HH, Zhu ZM. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer. Biochem Biophys Res Commun 2019; 516(3): 606-12.
[http://dx.doi.org/10.1016/j.bbrc.2019.06.096] [PMID: 31239153]
[16]
Hu Z, Song F, Hu Y, Liao T. Systematic analysis of the expression and prognostic significance of P4HA1 in pancreatic cancer and construction of a lncRNA-miRNA-P4HA1 regulatory axis. BioMed Res Int 2020; 2020: 8877334.
[http://dx.doi.org/10.1155/2020/8877334] [PMID: 33415167]
[17]
Li M, Wu F, Zheng Q, Wu Y, Wu Y. Identification of potential diagnostic and prognostic values of p4ha1 expression in lung cancer, breast cancer, and head and neck cancer. DNA Cell Biol 2020; 39(5): 909-17.
[http://dx.doi.org/10.1089/dna.2019.5170] [PMID: 32150689]
[18]
Xiong G, Stewart RL, Chen J, et al. Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance. Nat Commun 2018; 9(1): 4456.
[http://dx.doi.org/10.1038/s41467-018-06893-9] [PMID: 30367042]
[19]
Atkinson A, Renziehausen A, Wang H, et al. Collagen prolyl hydroxylases are bifunctional growth regulators in melanoma. J Invest Dermatol 2019; 139(5): 1118-26.
[http://dx.doi.org/10.1016/j.jid.2018.10.038] [PMID: 30452903]
[20]
Hu WM, Zhang J, Sun SX, et al. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas. Pathol Res Pract 2017; 213(11): 1365-9.
[http://dx.doi.org/10.1016/j.prp.2017.09.017] [PMID: 28964577]
[21]
Zhou Y, Jin G, Mi R, et al. Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane. Oncotarget 2017; 8(22): 35877-89.
[http://dx.doi.org/10.18632/oncotarget.16270] [PMID: 28415787]
[22]
Huntly BJ, Gilliland DG. Cancer biology: Summing up cancer stem cells. Nature 2005; 435(7046): 1169-70.
[http://dx.doi.org/10.1038/4351169a] [PMID: 15988505]
[23]
Sancho P, Barneda D, Heeschen C. Hallmarks of cancer stem cell metabolism. Br J Cancer 2016; 114(12): 1305-12.
[http://dx.doi.org/10.1038/bjc.2016.152] [PMID: 27219018]
[24]
Viale A, Pettazzoni P, Lyssiotis CA, et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 2014; 514(7524): 628-32.
[http://dx.doi.org/10.1038/nature13611] [PMID: 25119024]
[25]
Menendez JA, Joven J, Cufí S, et al. The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells. Cell Cycle 2013; 12(8): 1166-79.
[http://dx.doi.org/10.4161/cc.24479] [PMID: 23549172]
[26]
Shen YA, Pan SC, Chu I, Lai RY, Wei YH. Targeting cancer stem cells from a metabolic perspective. Exp Biol Med (Maywood) 2020; 245(5): 465-76.
[http://dx.doi.org/10.1177/1535370220909309] [PMID: 32102562]
[27]
Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4(11): 891-9.
[http://dx.doi.org/10.1038/nrc1478] [PMID: 15516961]
[28]
Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: What is so special about them? Trends Cell Biol 2008; 18(4): 165-73.
[http://dx.doi.org/10.1016/j.tcb.2008.01.006] [PMID: 18296052]
[29]
Shi R, Gao S, Zhang J, et al. Collagen prolyl 4-hydroxylases modify tumor progression. Acta Biochim Biophys Sin (Shanghai) 2021; 53(7): 805-14.
[http://dx.doi.org/10.1093/abbs/gmab065] [PMID: 34009234]
[30]
Gilkes DM, Bajpai S, Chaturvedi P, Wirtz D, Semenza GL. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol Chem 2013; 288(15): 10819-29.
[http://dx.doi.org/10.1074/jbc.M112.442939] [PMID: 23423382]
[31]
Agarwal S, Behring M, Kim HG, et al. Targeting P4HA1 with a small molecule inhibitor in a colorectal cancer PDX model. Transl Oncol 2020; 13(4): 100754.
[http://dx.doi.org/10.1016/j.tranon.2020.100754] [PMID: 32199274]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy